29.30p-0.05 (-0.17%)21 Feb 2024, 16:25
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Ekf Diagnostics Holdings PLC Fundamentals

Company NameEkf Diagnostics Holdings PLCLast Updated2024-02-21
IndustryMedical DevicesSectorHealthcare
Shares in Issue453.731 mMarket Cap£132.94 m
PE Ratio13.48Dividend per Share£0.01
Dividend Yield4.09Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0.0909
Debt Ratio0.0081Debt Equity Ratio0.0035
Asset Equity Ratio1.2602Cash Equity Ratio0.1404
Quick Ratio1.1725Current Ratio1.82
Price To Book Value2.0713ROCE0

Ekf Diagnostics Holdings PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ekf Diagnostics Holdings PLC Company Financials

Tangible Assets£21.71 m£17.87 m
Intangible Assets£33.77 m£41.89 m
Investments£1.12 m£7.79 m
Total Fixed Assets£57.53 m£67.56 m
Stocks£9.43 m£13.24 m
Debtors£8.59 m£11.13 m
Cash & Equivalents£9.21 m£20.34 m
Other Assets£925,000.00£15,000.00
Total Assets£89.29 m£115.12 m
Creditors within 1 year£11.74 m£13.65 m
Creditors after 1 year£3.03 m£6.73 m
Other Liabilities00
Total Liabilities£14.77 m£20.38 m
Net assets£74.52 m£94.74 m
Called up share capital£4.55 m£4.64 m
Share Premium£7.38 m£7.38 m
Profit / Loss-£8.94 m£21.43 m
Other Equity£73.35 m£94.12 m
Preference & Minorities£1.18 m£618,000.00
Total Capital Employed£74.52 m£94.74 m
Debt Ratio£0.01£0.02
Assets / Equity1.26021.2602
Cash / Equity0.14040.1404
Cash Flow20222021
Cash from operating activities£9.69 m£10.24 m
Cashflow before financing-£1.35 m£4.08 m
Increase in Cash-£10.28 m-£1.39 m
Turnover£66.64 m£81.84 m
Cost of sales£42.60 m£42.47 m
Gross Profit£24.04 m£39.37 m
Operating Profit-£8.97 m£21.75 m
Pre-Tax profit-£8.94 m£21.43 m

Ekf Diagnostics Holdings PLC Company Background

ActivitiesEKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
Latest Interim Date26 Sep 2023
Latest Fiscal Year End Date28 Mar 2023

Ekf Diagnostics Holdings PLC Directors

2016-04-08Mr. Ron ZwanzigerNon-Executive Director
2015-04-28Mr. Gordon James HallNon-Executive Director
2024-01-11Mr. Christopher Harwood Bernard MillsNon-Executive Director
2015-11-20Dr. Kevin William WilsonNon-Executive Director
2021-05-19Mr. Adam ReynoldsNon-Executive Director
2015-12-02Mr. Paul Andrew Peter FoulgerExecutive Director,Finance Director and Company Secretary
2023-04-21Mr. Julian Huw Baines MBEExecutive Director,Chairman
2017-04-18Mr. David Eric EvansNon-Executive Director,Deputy Chairman
2015-12-30Dr. Tito Bacarese-HamiltonExecutive Director,Chief Technology Officer
2011-08-09Mr. Anthony HutchinsonExecutive Director,Chief Executive
2023-09-12Mr. Stephen Michael YoungExecutive Director,Chief Financial Officer
2021-12-29Mr. Richard Anthony EvansExecutive Director,Finance Director and Chief Operating Officer
2017-04-18Mr. Salim HamirCompany Secretary
2023-02-06Mr. David Michael SalterExecutive Director,Chief Executive Officer

Ekf Diagnostics Holdings PLC Contact Details

Company NameEKF Diagnostics Holdings PLC
Address19 Stanwell Road, Penarth, Avon House, Cardiff, CF64 2EZ
Telephone+44 2920710570

Ekf Diagnostics Holdings PLC Advisors

Nominated AdviserN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
AuditorPricewaterhouseCoopers LLP
Phone+44 2920237000
Fax+44 2920802400
RegistrarLink Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
SolicitorBerry Smith Solicitors
Phone(02920) 345 511
Fax(02920) 345 945